Cited by 30Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesCytokine Signaling Pathways and Interactions

Insufficiency of Janus Kinase 2–Autonomous Leptin Receptor Signals for Most Physiologic Leptin Actions

Open access
Robertson, Scott, Ishida-Takahashi, Ryoko, Tawara, Isao, Hu, Jiang, Patterson, Christa M., Jones, Justin C., Kulkarni, Rohit N., Myers, Martin G.·2010·Diabetes

Abstract

OBJECTIVE: Leptin acts via its receptor (LepRb) to signal the status of body energy stores. Leptin binding to LepRb initiates signaling by activating the associated Janus kinase 2 (Jak2) tyrosine kinase, which promotes the phosphorylation of tyrosine residues on the intracellular tail of LepRb. Two previously examined LepRb phosphorylation sites mediate several, but not all, aspects of leptin action, leading us to hypothesize that Jak2 signaling might contribute to leptin action independently of LepRb phosphorylation sites. We therefore determined the potential role in leptin action for signals that are activated by Jak2 independently of LepRb phosphorylation (Jak2-autonomous signals). RESEARCH DESIGN AND METHODS: We inserted sequences encoding a truncated LepRb mutant (LepRbΔ65c, which activates Jak2 normally, but is devoid of other LepRb intracellular sequences) into the mouse Lepr locus. We examined the leptin-regulated physiology of the resulting Δ/Δ mice relative to LepRb-deficient db/db animals. RESULTS: The Δ/Δ animals were similar to db/db animals in terms of energy homeostasis, neuroendocrine and immune function, and regulation of the hypothalamic arcuate nucleus, but demonstrated modest improvements in glucose homeostasis. CONCLUSIONS: The ability of Jak2-autonomous LepRb signals to modulate glucose homeostasis in Δ/Δ animals suggests a role for these signals in leptin action. Because Jak2-autonomous LepRb signals fail to mediate most leptin action, however, signals from other LepRb intracellular sequences predominate.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db09-1556

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Δ/Δ mice with truncated LepRb exhibit a phenotype resembling db/db mice in energy homeostasis, neuroendocrine, and immune function, but have delayed progression to diabetes, suggesting modest improvement in glucose homeostasis.

    “These Δ/Δ mice exhibit a phenotype that resembles db/db mice where energy homeostasis, neuroendocrine and immune function are concerned, but also are characterized by a delayed progression to diabetes, suggesting a modest improvement in glucose homeostasis (150).”
  • Jak2-mediated signals independent of LepRb tyrosine phosphorylation contribute to the modulation of glucose homeostasis by leptin.

    “Jak2-mediated signals that are independent of LepRb tyrosine phosphorylation contribute to the modulation of glucose homeostasis by leptin (150).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 46 · Cited by 30

Authors
Robertson, S., Ishida-Takahashi, R., Tawara, I., Hu, J., Patterson, C. M., Jones, J. C., Kulkarni, R. N., & Myers, M. G.
Affiliations
  • University of Michigan (US)
  • Joslin Diabetes Center (US)
Corresponding author
Myers, Martin G.
Venue
Diabetes
Published
2010-01-12
Volume
59
Issue
4
Pages
782-790
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2148985060
Cited by
30
References
46
Citations by year
2025: 4 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 2 · 2014: 3 · 2013: 3 · 2012: 3
FWCI
1.89
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • American Diabetes Association
  • American Heart Association
  • Amylin Pharmaceuticals
  • University of Michigan
  • Regeneron Pharmaceuticals
  • National Institutes of Health
  • National Cancer Institute (CA46592, P30CA046592)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK20572, P60DK020572, DK57631, R37DK056731, DK-67536, R56DK067536, P30DK020572, R01DK067536)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
leptin, leptin receptor, JAK2, receptor tyrosine phosphorylation, energy homeostasis, glucose homeostasis, hypothalamic arcuate nucleus, neuroendocrine function, immune function, db/db mice
MeSH terms
Animals, Estrus, Female, Genetic Vectors, Hypothalamus, Male, Mice, Inbred C57BL, Phosphorylation, Plasmids, RNA, Spleen, T-Lymphocytes, Polymerase Chain Reaction, Mutagenesis, Site-Directed, DNA, Complementary, Mice, Knockout, Leptin, Mice, Janus Kinase 2, Receptors, Leptin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review